Case Study: Report: BioPharma Inc. In 2005‚ Phillip (Phil) Landgraf faced several glaring problems in the financial performance of his company‚ BioPharma‚ Inc. The firm had experienced a steep decline in profits and very high costs at its plants in Germany and Japan. Landgraf‚ the...
Our team of experts works with you to develop a tailored study design to meet your research needs across all areas of life sciences. Metabolon has pioneered Precision Metabolomics, the industry’s most comprehensive global metabolomics and lipidomics technology. We have built upon this technology ...
Lo, A. and S. Naraharisetti, 2014, "New Financing Methods in the Biopharma Industry: A Case Study of Royalty Pharma, Inc.," Journal of Investment Management 12, 4-19.Lo AW and Naraharisetti SV (2014): New Financing Methods in the...
Case Study CSL Behring: Targeting improvements in patient adoption and retention Read how the Hizentra app, built on the BrightInsight® Platform, gained high user adoption and an over 70% retention rate from 90 days to 12 months. Read Now ...
Watch the Case Study UPS Healthcare™ Cold Chain at work How to manage specialty pharmaceuticals with 2° to 8°C or -20° to -80°C requirements. Watch NowOpen the link in a new window Nephron Pharmaceuticals Case Study Getting desperately needed medications to patients quickly. ...
Pliant shares collapse as company halts fibrosis drug study In what one analyst called a “unique situation,” the company stopped dosing patients on the recommendation of trial monitors, but doesn’t yet know what led to their decision.
1037 Words 5 Pages Open Document In 2005, Phillip (Phil) Landgraf faced several glaring problems in the financial performance of his company, BioPharma, Inc. The firm had experienced a steep decline in profits and very high costs at its plants in Germany and Japan. Landgraf, the company '...
Sébastien Penninckx, Anne-Catherine Heuskin,Carine Michiels, Stéphane Lucas Nanomaterials 2019, 9(2), 295; Read More>> Keyword: gold nanoparticles; radiosensitization; thioredoxin reductase; radiation; prognosis; biochemical mechanism TA-PEG550-OCH3, TA-PEG400-NH2 PDL-1 Antibody Drug Conjugate for...
Veracyte Inc (NASDAQ:VCYT) Presents New Data That Builds A Case For Nasal Swabs In Lung Cancer Tests Chimerix (NASDAQ:CMRX) Announces Q3 2020 Financial Results And Provides Corporate updates Avenue Therapeutics Inc.’s (NASDAQ: ATXI) IV Tramadol Receives FDA Rejection ...
Theravance Biopharma, Inc.'sfocus is to deliverMedicines that Make a Difference®in people's lives. In pursuit of its purpose,Theravance Biopharmaleverages decades of expertise, which has led to the development of FDA-approved YUPELRI®(revefenacin) inhalation solution indicated for the maintenanc...